paeonol has been researched along with Colitis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Y; Chen, K; Chen, Y; Guan, X; Luo, X; Ni, C; Xie, X; Xu, B; Zhao, M; Zhou, L | 1 |
| Cai, H; Diao, J; Fan, Q; Lin, X; Shao, M; Sun, X; Yao, X; Yi, Z; Zhao, L | 1 |
| Chao, QL; Chen, DQ; Fan, HY; Jin, X; Liu, YR; Qiu, F; Shang, CH; Wang, J; Xia, ZM; Zhao, F | 1 |
| Ando, T; Goto, H; Hasegawa, M; Ishiguro, K; Kadomatsu, K; Maeda, O; Niwa, Y; Ohmiya, N; Xavier, R | 1 |
4 other study(ies) available for paeonol and Colitis
| Article | Year |
|---|---|
Paeonol alleviates ulcerative colitis in mice by increasing short-chain fatty acids derived from Clostridium butyricum.
Topics: Animals; Anti-Bacterial Agents; Clostridium butyricum; Colitis; Colitis, Ulcerative; Fatty Acids, Volatile; Mice; RNA, Ribosomal, 16S | 2023 |
ShaoYao decoction ameliorates colitis-associated colorectal cancer by downregulating proinflammatory cytokines and promoting epithelial-mesenchymal transition.
Topics: Acetophenones; Animals; Blotting, Western; Colitis; Colorectal Neoplasms; Cytokines; Down-Regulation; Drugs, Chinese Herbal; Epithelial-Mesenchymal Transition; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL | 2014 |
Anti-inflammatory and Anti-oxidative Activities of Paeonol and Its Metabolites Through Blocking MAPK/ERK/p38 Signaling Pathway.
Topics: Acetophenones; Animals; Anti-Inflammatory Agents; Antioxidants; Carrageenan; Cell Line; Colitis; Cyclooxygenase 2; Dextran Sulfate; Edema; Extracellular Signal-Regulated MAP Kinases; Hindlimb; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred BALB C; Nitric Oxide; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction; Tumor Necrosis Factor-alpha | 2016 |
Paeonol attenuates TNBS-induced colitis by inhibiting NF-kappaB and STAT1 transactivation.
Topics: Acetophenones; Animals; Anti-Inflammatory Agents; Colitis; Colon; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Enzymologic; Humans; Interferon-gamma; Jurkat Cells; Mice; Mice, Inbred BALB C; NF-kappa B; Nitric Oxide Synthase Type II; Promoter Regions, Genetic; RNA, Messenger; STAT1 Transcription Factor; Transcriptional Activation; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2006 |